|
|
| NDC Number | Brand Name | Generic Name | Labeler | Dosage Form | DEA Schedule | Marketing Start Date |
|---|---|---|---|---|---|---|
| 0008-0100 | Besponsa | inotuzumab ozogamicin | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2017-08-18 |
Loading full table content...